All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as
of the end of the calendar quarter for which the report is filed, and the total market value. The market value
column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in
accounts.
Filing 2021 Q1 - Restatement compared to 2020 Q4 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Ashwin Budhiraja
Chief Financial Officer
New York, New York
11/18/2022
This Amendment is being filed solely for the purpose of removing from the Form 13F Information Table certain shares of Class A Common Stock of Oscar Health, Inc. ("Class A Common") inadvertently included in the Form 13F filed by the Reporting Person for the quarter ended March 31, 2021. As of March 31, 2021, the Reporting Person or its affiliates exercised investment discretion over 32,859,064 shares of Class B Common Stock of Oscar Health, Inc. ("Class B Common"). While shares of Class A Common are Section 13(f) securities as defined in Rule 13f-1(c) under the Securities and Exchange Act of 1934, shares of Class B Common are not Section 13(f) securities and thus not reportable. For the avoidance of doubt, this Amendment is to correct a clerical error only, and there were no sales by the Reporting Person of shares of Class A Common or Class B Common during the quarter ended March 31, 2021.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.